RDY – dr. reddy's laboratories ltd (US:NASDAQ)
Stock Stats
News
Trump's latest tariff threat ends brief reprieve for Indian pharma stocks [Yahoo! Finance Canada]
Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia
Henlius 2024 Annual Results: Steady Revenue Growth with a Net Profit of RMB820.5 million, Up by 50.3% YoY [Yahoo! Finance]
Alvotech and Dr. Reddy's gets FDA nod for Biologic License Application for AVT03 [Seeking Alpha]
Alvotech and Dr. Reddy’s Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
Form 6-K DR REDDYS LABORATORIES For: Mar 22
Form 6-K DR REDDYS LABORATORIES For: Mar 21
Form 6-K DR REDDYS LABORATORIES For: Mar 13
Form 6-K DR REDDYS LABORATORIES For: Mar 12
Form 6-K DR REDDYS LABORATORIES For: Mar 07
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.